MedPath

Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery

Not Applicable
Completed
Conditions
Orthopedic Surgery
Interventions
Registration Number
NCT02744508
Lead Sponsor
Yonsei University
Brief Summary

Postoperative nausea and vomiting (PONV) is related with extended hospital day and risk factor of aspiration pneumonia. Postoperative patient controlled intravenous analgesia is related with postoperative nausea and vomiting. Selective 5-HT3 antagonist, Palonosetron, is the most recent medication for prevention of PONV. Purpose of our study is comparison of PONV preventive effect of palonosetron and combination of palonosetron and dexamethasone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
202
Inclusion Criteria
  • patients who are undergoing minor orthopedic surgery.
  • IV patient controlled analgesia
Exclusion Criteria
    1. minority (0~19 year)
  • patients who are belongs to ASA class 3 or more, and have underlying complicated cardiovascular or psychological disease.
  • Steroid medication
  • Diabetes Mellitus medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PD grouppalonosetron with dexamethasonePalonosetron and dexamethasone group
P grouppalonosetronPalonosetron group
Primary Outcome Measures
NameTimeMethod
incidence of clinically significant PONV with PONV impact scale72 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath